Concepedia

Antreas Hindoyan

AH

Statistics

Publications

14

Citations

1.1K

H-Index

14

Active since

2011

Affiliations

Amgen (United States)(Current)

The University of Texas MD Anderson Cancer Center

University of California, Los Angeles

Peter MacCallum Cancer Centre

University Hospital Cologne

Antreas Hindoyan is an author at Amgen (United States) specializing in medicine, oncology, and pharmacology.

Publications per year

2011–2025

14

Publications

14

Integrative Survival-Based Molecular Profiling of Human Pancreatic Cancer

Timothy R. Donahue, Linh M. Tran, Reginald Hill et al. · Clinical Cancer Research · 2012 · 215 citations

Medicine, Bioinformatics, Oncology +12

An optimized small molecule inhibitor cocktail supports long-term maintenance of human embryonic stem cells

Hideaki Tsutsui, Bahram Valamehr, Antreas Hindoyan et al. · Nature Communications · 2011 · 172 citations · Full text

Life Sciences, Cell Biology, Pharmacology +15

Long-Term Outcomes and Molecular Correlates of Sotorasib Efficacy in Patients With Pretreated <i>KRAS</i> G12C-Mutated Non–Small-Cell Lung Cancer: 2-Year Analysis of CodeBreaK 100

Grace K. Dy, Ramaswamy Govindan, Vamsidhar Velcheti et al. · Journal of Clinical Oncology · 2023 · 149 citations · Full text

Medicine, Oncology, Pharmacology +14

Identification of CD166 as a Surface Marker for Enriching Prostate Stem/Progenitor and Cancer Initiating Cells

Jing Jiao, Antreas Hindoyan, Shunyou Wang et al. · PLoS ONE · 2012 · 111 citations · Full text

Medicine, Cell Biology, Oncology +16

Updated results from phase I dose-escalation study of AMG 330, a bispecific T-cell engager molecule, in patients with relapsed/refractory acute myeloid leukemia (R/R AML).

Farhad Ravandi, Roland B. Walter, Marion Subklewe et al. · Journal of Clinical Oncology · 2020 · 105 citations

Medicine, Oncology, Pharmacology +14

1–5 of 14